Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
455.3 USD | +2.77% | -0.35% | +11.91% |
May. 31 | BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480 | MT |
May. 31 | Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing | MT |
ETFs positioned on Vertex Pharmaceuticals Incorporated
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.67% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - | |
5.20% | 2 M€ | -.--% | ||
4.81% | 7 M€ | -.--% | - | |
4.05% | 110 M€ | +8.20% | - | |
3.53% | 1 M€ | -.--% | - | |
2.32% | 2 M€ | -.--% | ||
2.28% | 8 M€ | -.--% | ||
1.99% | 12 M€ | +15.09% | - | |
1.93% | 0 M€ | -.--% | - | |
1.71% | 2 M€ | -25.75% | ||
1.63% | 17 M€ | +6.09% | - | |
1.61% | 253 M€ | +5.88% | ||
1.58% | 9 M€ | -4.31% | - | |
1.10% | 204 M€ | +10.54% | ||
1.06% | 1,100 M€ | +2.49% | ||
0.87% | 9 M€ | -.--% | - | |
0.82% | 13 M€ | -.--% | - | |
0.82% | 3 M€ | +15.16% | - | |
0.82% | 4 M€ | -.--% | - | |
0.81% | 26 M€ | +16.85% | - | |
0.73% | 15 M€ | -.--% | - | |
0.69% | 5 M€ | -72.95% | - | |
0.68% | 3 M€ | -.--% | - | |
0.51% | 727 M€ | +7.40% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated